as of 08-14-2026 3:13pm EST
Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.
| Founded: | 2009 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 1.7M | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 169.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.05 | EPS Growth: | -7179.59 |
| 52 Week Low/High: | $0.05 - $4.21 | Next Earning Date: | 04-15-2026 |
| Revenue: | $100,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | -0.46 | Index: | N/A |
| Free Cash Flow: | -16256000.0 | FCF Growth: | N/A |
10% Owner
Avg Cost/Share
$0.97
Shares
2,280
Total Value
$2,211.60
Owned After
111,024
SEC Form 4
10% Owner
Avg Cost/Share
$0.94
Shares
4,016
Total Value
$3,791.10
Owned After
113,304
SEC Form 4
10% Owner
Avg Cost/Share
$0.95
Shares
924
Total Value
$874.10
Owned After
111,024
SEC Form 4
10% Owner
Avg Cost/Share
$0.94
Shares
926
Total Value
$873.22
Owned After
113,304
SEC Form 4
10% Owner
Avg Cost/Share
$0.94
Shares
383
Total Value
$360.79
Owned After
111,024
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | PFSA | 10% Owner | Aug 11, 2026 | Sell | $0.97 | 2,280 | $2,211.60 | 111,024 | |
| HRT FINANCIAL LP | PFSA | 10% Owner | Aug 10, 2026 | Buy | $0.94 | 4,016 | $3,791.10 | 113,304 | |
| HRT FINANCIAL LP | PFSA | 10% Owner | Aug 7, 2026 | Sell | $0.95 | 924 | $874.10 | 111,024 | |
| HRT FINANCIAL LP | PFSA | 10% Owner | Aug 6, 2026 | Buy | $0.94 | 926 | $873.22 | 113,304 | |
| HRT FINANCIAL LP | PFSA | 10% Owner | Aug 5, 2026 | Sell | $0.94 | 383 | $360.79 | 111,024 |
See how PFSA stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "PFSA Profusa Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.